Literature DB >> 12793559

Survival analysis is a better estimate of recurrent disc herniation.

P Gaston1, R W Marshall.   

Abstract

Studies on recurrent disc herniation quote rates of recurrence without regard to the times of recurrence and the influence of longer follow-up. Our objective was to assess the use of survival analysis to measure the rate of revision after lumbar microdiscectomy. We undertook a retrospective analysis of the hospital records of 993 patients who underwent lumbar microdiscectomy over a period of ten years. After calculating the overall rate of revision for the mean length of follow-up, we carried out a survival analysis using the life-table method. During the study period 49 patients had a revision microdiscectomy. This gave an overall rate of revision of 4.9% at a mean follow-up of 5.25 years. Using survival analysis, the rate of revision was 7.9% at a follow-up of ten years when the number at risk was 84. Survival analysis gives a more accurate estimation of the true rate of recurrence for patients undergoing lumbar microdiscectomy. The method allows better comparison between different interventions for disc herniation.

Entities:  

Mesh:

Year:  2003        PMID: 12793559     DOI: 10.1302/0301-620x.85b4.13813

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  20 in total

1.  Survivorship analysis of 150 consecutive patients with DIAM™ implantation for surgery of lumbar spinal stenosis and disc herniation.

Authors:  Yoo-Joon Sur; Chae-Gwan Kong; Jong-Beom Park
Journal:  Eur Spine J       Date:  2010-10-17       Impact factor: 3.134

2.  The implantation of non-cell-based materials to prevent the recurrent disc herniation: an in vivo porcine model using quantitative discomanometry examination.

Authors:  Yao-Hung Wang; Tzong-Fu Kuo; Jaw-Lin Wang
Journal:  Eur Spine J       Date:  2007-01-25       Impact factor: 3.134

3.  Association of age with incidence and timing of recurrence after microdiscectomy for lumbar disc herniation.

Authors:  Alessandro Siccoli; Marc L Schröder; Victor E Staartjes
Journal:  Eur Spine J       Date:  2020-12-14       Impact factor: 3.134

4.  What is the Rate of Revision Discectomies After Primary Discectomy on a National Scale?

Authors:  Sohrab S Virk; Ashish Diwan; Frank M Phillips; Harvinder Sandhu; Safdar N Khan
Journal:  Clin Orthop Relat Res       Date:  2017-08-28       Impact factor: 4.176

5.  Recurrence of radicular pain or back pain after nonsurgical treatment of symptomatic lumbar disk herniation.

Authors:  Pradeep Suri; James Rainville; David J Hunter; Ling Li; Jeffrey N Katz
Journal:  Arch Phys Med Rehabil       Date:  2012-04       Impact factor: 3.966

6.  Sciatica caused by disc herniation: Why is Chymopapain Chemonucleolysis denied to our patients?

Authors:  Douglas Wardlaw
Journal:  Int J Spine Surg       Date:  2016-12-31

Review 7.  Incidence of Low Back Pain After Lumbar Discectomy for Herniated Disc and Its Effect on Patient-reported Outcomes.

Authors:  Scott L Parker; Stephen K Mendenhall; Saniya S Godil; Priya Sivasubramanian; Kevin Cahill; John Ziewacz; Matthew J McGirt
Journal:  Clin Orthop Relat Res       Date:  2015-06       Impact factor: 4.176

8.  Recurrence of Pain After Usual Nonoperative Care for Symptomatic Lumbar Disk Herniation: Analysis of Data From the Spine Patient Outcomes Research Trial.

Authors:  Pradeep Suri; Adam M Pearson; Emily A Scherer; Wenyan Zhao; Jon D Lurie; Tamara S Morgan; James N Weinstein
Journal:  PM R       Date:  2015-11-06       Impact factor: 2.298

9.  Clinical Outcomes after Microdiscectomy for Recurrent Lumbar Disk Herniation: A Single-Center Study.

Authors:  Hossein Mashhadinezhad; Ebrahim Sarabi; Sara Mashhadinezhad; Babak Ganjeifar
Journal:  Arch Bone Jt Surg       Date:  2018-09

10.  Pain Recurrence After Discectomy for Symptomatic Lumbar Disc Herniation.

Authors:  Pradeep Suri; Adam M Pearson; Wenyan Zhao; Jon D Lurie; Emily A Scherer; Tamara S Morgan; James N Weinstein
Journal:  Spine (Phila Pa 1976)       Date:  2017-05-15       Impact factor: 3.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.